Published in J Child Adolesc Psychopharmacol on February 01, 2010
Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction (2013) 1.62
Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies. J Cent Nerv Syst Dis (2012) 0.77
Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges. Prim Care Companion CNS Disord (2013) 0.76
Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage. Eur J Drug Metab Pharmacokinet (2017) 0.75
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry (2006) 3.68
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med (2006) 3.57
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry (2008) 3.52
Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 2.37
Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry (2010) 2.31
Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08
Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry (2005) 1.86
Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.79
Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr (2005) 1.74
Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry (2007) 1.74
Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biol Psychiatry (2006) 1.73
Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations. J Am Acad Child Adolesc Psychiatry (2011) 1.66
The diagnosis and treatment of Munchausen's syndrome. Gen Hosp Psychiatry (2003) 1.51
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry (2008) 1.41
The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med (2003) 1.41
Core competencies for fellowship training in psychosomatic medicine: a collaborative effort by the APA Council on Psychosomatic Medicine, the ABPN Psychosomatic Committee, and the Academy of Psychosomatic Medicine. Psychosomatics (2009) 1.39
Central pontine myelinolysis manifested by temporary blindness: a possible complication of lithium toxicity. Ann Clin Psychiatry (2002) 1.38
Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics (2010) 1.33
Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 1.30
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr (2006) 1.29
The impact of serious mental illness on health and healthcare. Psychosomatics (2010) 1.28
Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict (2007) 1.22
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics (2009) 1.20
Visual hallucinations: differential diagnosis and treatment. Prim Care Companion J Clin Psychiatry (2009) 1.20
Insertion of foreign bodies (polyembolokoilamania): underpinnings and management strategies. Prim Care Companion CNS Disord (2012) 1.19
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry (2009) 1.14
Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry (2005) 1.11
Assessing cannabis use in adolescents and young adults: what do urine screen and parental report tell you? J Child Adolesc Psychopharmacol (2005) 1.09
Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry (2002) 1.05
Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep (2006) 1.04
Falls in the general hospital: association with delirium, advanced age, and specific surgical procedures. Psychosomatics (2009) 1.04
Dread complications of catatonia: a case discussion and review of the literature. Prim Care Companion J Clin Psychiatry (2008) 1.03
Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry (2007) 1.01
Conversion disorder presenting with neurologic and respiratory symptoms. Prim Care Companion J Clin Psychiatry (2005) 1.00
Linezolid and serotonin syndrome. Prim Care Companion J Clin Psychiatry (2009) 1.00
Neuropsychiatric effects of prescription drug abuse. Neuropsychol Rev (2007) 0.99
Linking electronic health record-extracted psychosocial data in real-time to risk of readmission for heart failure. Psychosomatics (2011) 0.99
Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features. J Clin Psychiatry (2011) 0.96
The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics (2012) 0.95
Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry (2011) 0.93
The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families. Nicotine Tob Res (2008) 0.93
Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci (2007) 0.92
Pharmacotherapy of adolescent substance use disorders: a review of the literature. J Child Adolesc Psychopharmacol (2005) 0.91
Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry (2002) 0.91
Successful implementation of an alcohol-withdrawal pathway in a general hospital. Psychosomatics (2008) 0.90
Prior discharges against medical advice and withdrawal of consent: what they can teach us about patient management. Prim Care Companion CNS Disord (2011) 0.90
Comorbid pain, depression, and anxiety: multifaceted pathology allows for multifaceted treatment. Harv Rev Psychiatry (2009) 0.90
Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J Child Psychol Psychiatry (2009) 0.90
Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr (2005) 0.90
Depressogenic effects of medications: a review. Dialogues Clin Neurosci (2011) 0.89
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol (2009) 0.89
The effect of testosterone levels on mood in men: a review. Psychosomatics (2013) 0.88
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2006) 0.88
Psychiatric considerations in the patient receiving organ transplantation: a clinical case conference. Gen Hosp Psychiatry (2004) 0.88
Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature. Prim Care Companion J Clin Psychiatry (2008) 0.88
A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med (2007) 0.88
Documentation of decision-making capacity, informed consent, and health care proxies: a study of surrogate consent. Psychosomatics (2011) 0.87
Deriving phenotypes for molecular genetic studies of substance use disorders: a family study approach. Drug Alcohol Depend (2006) 0.87
Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr (2005) 0.86
Does exposure to parental substance use disorders increase substance use disorder risk in offspring? A 5-year follow-up study. Am J Addict (2013) 0.86
Temporal association between childhood psychopathology and substance use disorders: findings from a sample of adults with opioid or alcohol dependency. Psychiatry Res (2002) 0.86
Alcohol use during pregnancy: prevalence and impact. Prim Care Companion J Clin Psychiatry (2007) 0.86
Insulin overdose among patients with diabetes: a readily available means of suicide. Prim Care Companion J Clin Psychiatry (2009) 0.86
Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J Child Adolesc Psychopharmacol (2005) 0.85
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry (2012) 0.85
Neuropsychiatric manifestations of multiple sclerosis. Prim Care Companion J Clin Psychiatry (2008) 0.85
Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders. Drug Alcohol Depend (2007) 0.84
New developments in the treatment of ADHD. J Clin Psychiatry (2006) 0.84
The use of DBT skills in the treatment of difficult patients in the General Hospital. Psychosomatics (2003) 0.84
Staying against advice: refusal to leave the hospital. Prim Care Companion J Clin Psychiatry (2010) 0.83
Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. Int J Neuropsychopharmacol (2003) 0.83
Complications of carbon monoxide poisoning: a case discussion and review of the literature. Prim Care Companion J Clin Psychiatry (2009) 0.83
Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination. J Am Acad Child Adolesc Psychiatry (2003) 0.83
Denial of cardiac illness: consequences and management. Prim Care Companion CNS Disord (2011) 0.83
Consultants' conflicts: a case discussion of differences and their resolution. Psychosomatics (2008) 0.83
Aripiprazole-related tardive dyskinesia. CNS Spectr (2006) 0.83
Demoralization in medical practice. Prim Care Companion J Clin Psychiatry (2007) 0.82
Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. J Am Acad Child Adolesc Psychiatry (2006) 0.82
Reasons for substance use among adolescents with bipolar disorder. Am J Addict (2010) 0.82
Does the medicating ADHD increase or decrease the risk for later substance abuse? Rev Bras Psiquiatr (2003) 0.82
The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Curr Psychiatry Rep (2014) 0.82
Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children. BMC Psychiatry (2009) 0.81
Impact of executive function deficits in youth with bipolar I disorder: a controlled study. Psychiatry Res (2011) 0.81
Does social class predict substance problems in young adults with ADHD? Am J Addict (2007) 0.81
Clinical experience with the management of schizophrenia in the general hospital. Psychosomatics (2003) 0.81
Psychotic symptoms in the elderly. Prim Care Companion J Clin Psychiatry (2005) 0.81
"Playing possum:" differential diagnosis, work-up, and treatment of profound interpersonal withdrawal. Psychosomatics (2011) 0.81
Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder. Bipolar Disord (2009) 0.81
Medical complications of psychiatric treatment. Crit Care Clin (2008) 0.81
Teaching residents about emotional intelligence and its impact on leadership. Acad Psychiatry (2014) 0.81
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biol Psychiatry (2006) 0.80
Reactions to amputation: recognition and treatment. Prim Care Companion J Clin Psychiatry (2007) 0.80
Clinical Challenges to the Delivery of End-of-Life Care. Prim Care Companion J Clin Psychiatry (2006) 0.80
Individual risk profiles for postoperative delirium after joint replacement surgery. Psychosomatics (2011) 0.79
Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder. Bipolar Disord (2009) 0.79
Cocaine and opioid use during pregnancy: prevalence and management. Prim Care Companion J Clin Psychiatry (2008) 0.79
Acute psychiatric manifestations of stroke: a clinical case conference. Psychosomatics (2003) 0.79